Diagnostic Imaging Can Rule Out Coronary Artery Disease in Half of Low-Risk Patients with Atypical Chest Pain

In “Ruling Out Coronary Artery Disease in Women with Atypical Chest Pain; Results of Calcium Score Combined with Coronary Computed Tomography Angiography and Associated Radiation Exposure,” Friso van der Zant, MD, PhD and coauthors from Medical Center Alkmaar, The Netherlands, evaluated the results of CCTA, a well-established, sensitive method of visualizing non-obstructive coronary artery disease, and calcium scoring to determine the presence of non-calcified plaques in the coronary arteries, among women over an 18-month period. The authors concluded that the ability to exclude a diagnosis of CAD in about half of patients can have a substantial impact on patient management.

“This study suggests that CCTA combined with calcium scoring is a useful diagnostic tool for excluding coronary artery disease in women with atypical chest pain, with minimal concerns about radiation exposure,” says Susan G. Kornstein, MD, Editor-in-Chief of Journal of Women’s Health, Executive Director of the Virginia Commonwealth University Institute for Women’s Health, Richmond, VA, and President of the Academy of Women’s Health.

About the Journal
Journal of Women’s Health, published monthly, is a core multidisciplinary journal dedicated to the diseases and conditions that hold greater risk for or are more prevalent among women, as well as diseases that present differently in women. The Journal covers the latest advances and clinical applications of new diagnostic procedures and therapeutic protocols for the prevention and management of women’s healthcare issues. Complete tables of content and a sample issue may be viewed on the Journal of Women’s Health website. Journal of Women’s Health is the official journal of the Academy of Women’s Health and the Society for Women’s Health Research.

About the Academy
Academy of Women’s Health is an interdisciplinary, international association of physicians, nurses, and other health professionals who work across the broad field of women’s health, providing its members with up-to-date advances and options in clinical care that will enable the best outcomes for their women patients. The Academy’s focus includes the dissemination of translational research and evidence-based practices for disease prevention, diagnosis, and treatment of women across the lifespan.

About the Publisher
Mary Ann Liebert, Inc., publishers is a privately held, fully integrated media company known for establishing authoritative peer-reviewed journals in many promising areas of science and biomedical research, including Violence and Gender, LGBT Health, Population Health Management, and Breastfeeding Medicine. Its biotechnology trade magazine, Genetic Engineering & Biotechnology News (GEN), was the first in its field and is today the industry’s most widely read publication worldwide. A complete list of the firm’s 80 journals, books, and newsmagazines is available on the Mary Ann Liebert, Inc., publishers website.